Northwest Biotherapeutics Inc (NWBO): EPS (Basic)

Annual figures by period end, from SEC filings.

-$0.04
Year ended 2025-12-31
$0.212010-12-31: -$0.412011-12-31: -$0.352019-12-31: -$0.042020-12-31: -$0.732021-12-31: $0.212022-12-31: -$0.102023-12-31: -$0.062024-12-31: -$0.072025-12-31: -$0.04-$0.04
2010-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$0.04n/m2026-04-15, From 2025-01-01
2024-12-31-$0.07n/m2026-04-15, From 2024-01-01
2023-12-31-$0.06n/m2025-03-31, From 2023-01-01
2022-12-31-$0.10n/m2024-03-05, From 2022-01-01
2021-12-31$0.21n/m2024-03-05, From 2021-01-01
2020-12-31-$0.73n/m2023-02-28, From 2020-01-01
2019-12-31-$0.04n/a2022-03-01, From 2019-01-01
No annual figure between 2011-12-31 and 2019-12-31.
2011-12-31-$0.35n/m2012-04-13, From 2011-01-01
2010-12-31-$0.41n/a2012-04-13, From 2010-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Northwest Biotherapeutics Inc (NWBO)2025-12-31-$0.04n/m
Avenue Therapeutics, Inc. (ATXI)2025-12-31-$0.93n/m
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31-$1.34n/m
IGC Pharma, Inc. (IGC)2025-03-31-$0.09n/m
Vistagen Therapeutics, Inc. (VTGN)2026-03-31-$1.83n/m
Longeveron Inc. (LGVN)2025-12-31-$1.29n/m
Neuphoria Therapeutics Inc. (NEUP)2026-06-30-$3.06n/m
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31-$0.45n/m
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31-$9.13n/m

Compare NWBO, ATXI, NRXP, IGC side by side · Screen every company in Pharmaceutical Preparations ↗